Science Resources RSS Feeds
|
 |
 |
 |
Ace Inhibitors Current Events | Ace Inhibitors News
|
| Page
1 of
19 |
376 Results |
|
|
|
Sort By:
Page Views | Date |
Aspirin Does Not Reduce Effectiveness Of ACE Inhibitors
A systematic review in this week's issue of THE LANCET provides clarification for the debate about the use of angiotensin-converting-enzyme (ACE) inhibitors in combination with aspirin for the treatment of cardiovascular disease-combination therapy does not reduce the effect of ACE inhibition. Previous research has suggested that ACE inhibitors... view more... (2002-10-02)
ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease
ngiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease. view more (2006-04-11)
Ace Inhibitors Could Slow Muscle Decline (p 926)
Angiotensin-converting enzyme (ACE) inhibitors, a class of drugs used to lower blood pressure, could also be protective against the decline in muscle strength in elderly women suggest authors of a study in this week's issue of THE LANCET. ACE inhibitors are known to prevent the decline in physical function in patients with congestive heart failure... view more... (2002-03-13)
Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers
Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension. view more (2006-05-24)
Angiotensin inhibitors and receptor blockers linked to lower risk of nonmelanoma skin cancer
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute. view more (2008-08-27)
First trimester use of ACE inhibitors implicated in birth defects
The Food and Drug Administration is examining study data from Vanderbilt University Medical Center researchers, published this week in the New England Journal of Medicine, to determine if new warnings should be placed on common blood pressure medications indicating an increased risk of birth defects for babies whose mothers take these medications... view more... (2006-06-08)
Blood pressure medication to treat multiple sclerosis?
Conventional blood pressure medication can treat inflammation in an animal model mimicking multiple sclerosis (MS). This discovery was made by Dr. Michael Platten, head consultant at the department of Neurooncology at Heidelberg University Hospital and head of the Helmholtz Experimental Neuroimmunology Junior Research Group on at the German Cancer... view more... (2009-08-19)
Heart failure patients at greatest risk of death least likely to receive appropriate medications
Even though certain medications such as ACE inhibitors reduce the risk of death for patients with heart failure, patients at greatest risk often are not prescribed these medications. view more (2005-09-14)
Some hypertension drugs may help reduce dementia risk
Some high blood pressure medicines may help protect older adults from declines in memory and other cognitive function, according to new research from Wake Forest University School of Medicine. view more (2007-05-07)
Diabetes drugs of the future
COMMON blood-pressure drugs that help prevent the life-threatening complications of diabetes may do so by slowing the accelerated ageing from which diabetics suffer. The discovery could one day lead to drugs that delay some of the symptoms of ageing in everyone. People with diabetes tend to age rapidly, particularly if they have type 1 diabetes,... view more... (2002-10-02)
Some blood pressure drugs may help protect against dementia, study shows
A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine. view more (2009-07-23)
Enzyme is key to clogged arteries
Scientists at Queen Mary, University of London have made an important discovery in understanding what causes arteries to clog up. view more (2009-09-24)
Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
Common blood pressure medications might help block the spread of pancreatic cancer, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found. view more (2006-12-08)
Finding protection from tumor growth in unexpected places
Researchers have discovered that an enzyme commonly involved in regulating blood pressure also provides protection from tumor growth when strongly expressed in immune cells. view more (2007-06-06)
ESC Congress 2004: First long-term comparative study of an ARB and an ACE inhibitor in patient with type 2 diabetes, hypertension and early nephropathy
Results from the first long-term comparative study of an angiotensin receptor blocker (ARB) and an ACE inhibitor in patients with type 2 diabetes, hypertension and early nephropathy were presented today.1 The five year DETAIL (Diabetics Exposed to Telmisartan And enalaprIL) study showed that telmisartan provides comparable renoprotective effects... view more... (2004-08-31)
Homing in on blood pressure genes may lead to targeted therapy
For the first time, researchers have mapped a genetic location that explains why certain blood pressure-lowering drugs aren't effective for some people, according to researchers at the 2005 American Heart Association High Blood Pressure Research meeting. view more (2005-09-26)
NEW DRUG TREATMENT COULD PROVIDE LONG-TERM BENEFIT FOR HEART-ATTACK PATIENTS (p 1385)
Patients with acute myocardial infarction (heart attack), complicated by left-ventricular systolic dysfunction, could benefit from the ß-blocker carvedilol, conclude authors of a study in this week's issue of THE LANCET. In a randomised, placebo-controlled trial, this drug reduced the frequency of death from all causes, death from... view more... (2001-05-03)
Enzyme may hold key to new treatment of diabetic kidney disease
Northwestern University Feinberg School of Medicine researchers have found that an enzyme called ACE2 may hold the potential to treat diabetic kidney disease, the most common form of kidney disease. view more (2006-11-08)
Passover's matzoh ball soup may be good for your health
With the Jewish holiday of Passover beginning at sundown next Wednesday, April 8, a staple of the traditional dinner -- chicken soup with matzoh balls -- may take on medicinal importance based on findings published in the American Chemical Society's Journal of Agricultural and Food Chemistry. view more (2009-04-03)
More than half of older diabetics lack medicines that protect kidneys and heart
Only 43 percent of older people with diabetes receive medicines that could protect their heart and kidneys, despite the fact that virtually all of them could benefit from those drugs. view more (2006-04-19)
|
|
| Page
1 of
19 |
376 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
